IRIS-Coroflex NEO Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility criteria
Qualifiers
Patients ≥ 19 years old
Patients receiving Coroflex ISAR NEO stents.
The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Disqualifiers
Patients with a mixture of other DESs
Terminal illness with life expectancy <1 year.
Patients with cardiogenic shock
Trial design
Treatments tested in this trial
- Coroflex ISAR NEO stent
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
The CardioVascular Research Foundation (CVRF)
Collaborator
Source ClinicalTrials.gov